Cannabidivarol ​​for Anti-inflammatory

Cannabidivarol (CAS 24274-48-4)​​ is a non-psychoactive propyl analogue of cannabidiol (CBD), distinguished by its shorter three-carbon side chain instead of CBD’s pentyl chain. This structural variation influences its pharmacological profile, enhancing its research relevance as a potential therapeutic agent, particularly for its noted anticonvulsant properties and emerging applications in treating neurological disorders such as epilepsy. As a minor cannabinoid, it also serves as a critical tool for studying structure-activity relationships within the endocannabinoid system.